Alhambra Investment Partners LLC Astrazeneca PLC Transaction History
Alhambra Investment Partners LLC
- $198 Million
- Q2 2025
A detailed history of Alhambra Investment Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 4,580 shares of AZN stock, worth $391,040. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,580Holding current value
$391,040% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.43 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.52 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.93 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.68 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.66 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $265B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...